Related Experiment Video
Updated: Aug 17, 2026

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
Use of third-generation cephalosporins. Anaerobes
1Department of Surgery, Tulane University School of Medicine, New Orleans.
Abstract:
The third-generation cephalosporins have an increased spectrum of activity against gram-negative bacteria, moderate activity against anaerobic bacteria, and reduced anti-gram-positive activity as compared with earlier cephalosporins. This spectrum allows the drugs to be considered as monotherapy for the treatment of mixed aerobic-anaerobic infections and as prophylaxis in patients in whom such mixed flora are expected. In vitro testing of anaerobes with the third-generation cephalosporins shows susceptibility to be method dependent, with regional differences also observed. The microtube broth dilution method shows the best relationship to in vivo results. Moreover, the apparent in vitro susceptibility or resistance does not always correlate with clinical efficacy. Clinical studies indicate that the expanded-spectrum third-generation cephalosporins may be used in place of combination therapy in patients with polymicrobial infection or as prophylaxis when mixed microflora are expected.
Insights
Third-generation cephalosporins offer broad-spectrum activity, effective for mixed aerobic-anaerobic infections and prophylaxis. Clinical use shows they can replace combination therapy in polymicrobial infections.
Area of Science:
- Pharmacology
- Microbiology
- Infectious Diseases
Background:
- Third-generation cephalosporins exhibit enhanced activity against Gram-negative bacteria.
- They possess moderate activity against anaerobic bacteria but reduced activity against Gram-positive bacteria compared to earlier generations.
Purpose of the Study:
- To evaluate the clinical utility of third-generation cephalosporins for treating mixed aerobic-anaerobic infections.
- To assess their role in prophylaxis for patients with expected mixed flora.
- To analyze the correlation between in vitro susceptibility and clinical efficacy.
Main Methods:
- In vitro testing of anaerobic bacteria susceptibility using various methods, including microtube broth dilution.
- Review of clinical studies on the use of third-generation cephalosporins in polymicrobial infections and prophylaxis.
Main Results:
- In vitro susceptibility of anaerobes is method-dependent, with regional variations observed.
- The microtube broth dilution method demonstrated the best correlation with in vivo results.
- Clinical efficacy does not always align with in vitro susceptibility or resistance patterns.
Conclusions:
- Third-generation cephalosporins are suitable for monotherapy in mixed aerobic-anaerobic infections.
- They can be used as prophylaxis when mixed microflora are anticipated.
- These agents may serve as alternatives to combination therapy for polymicrobial infections.
Related Concept Videos
Antibiotic Selection
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
Clinical Significance of Antibiotic Resistance

